Real-time enrollment status for this adhd clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:25 PM UTC
| NCT Number | NCT04781140 |
| Recruiting Status | Recruiting |
| Condition | ADHD |
| Phase | PHASE4 |
| Target Enrollment | 286 participants |
| Active Locations | 47 sites in the US |
| Sponsor | Supernus Pharmaceuticals, Inc. |
| Last Updated on CT.gov | February 18, 2026 (Feb 18, 2026) |
As of July 18, 2026: Clinical trial NCT04781140 is currently recruiting participants. This phase4 study for adhd is actively seeking new participants at 47 locations across the United States. The study is sponsored by Supernus Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04781140 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 47 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04781140 was last updated Feb 18, 2026 (February 18, 2026). HelloStudys verifies this status automatically.